Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo

Circulation

Volumn 108, Issue 14, 2003, Pages 1746-1752

  Yoshida, Kenji ^b   Nishida, Wataru ^a   Hayashi, Ken'ichiro ^a   Ohkawa, Yasuyuki ^a   Ogawa, Akira ^b   Aoki, Junken ^b   Arai, Hiroyuki ^b   Sobue, Kenji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Atherosclerosis; Cells; Kinases; Muscle, smooth; Phenotype

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG MECHANISM; HISTOPATHOLOGY; INTIMA; MALE; METABOLIC REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RISK FACTOR; SMOOTH MUSCLE FIBER; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; CAROTID ARTERY, COMMON; CAROTID STENOSIS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FATS, UNSATURATED; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0141919734     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000089374.35455.F3     Document Type: Article

References (17)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Steinberg D, Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 1997;95:1062-1071.
3. Hayashi K, Saga H, Chimori T, et al. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem. 1998;273:28860-28867.
4. Hayashi K, Takahashi M, Kimura K, et al. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol. 1999;145:727-740.
5. Hayashi K, Takahashi M, Nishida W, et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res. 2001;89:251-258.
6. Moolenaar WH, Kranenburg O, Postma FR, et al. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol. 1997;9:168-173.
7. Tokumura A, Fukuzawa K, Tsukatani H. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species. Lipids. 1978;13:572-574.
8. Eichholtz T, Jalink K, Fahrenfort I, et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J. 1993;291:677-680.
9. Igarashi M, Takeda Y, Mori S, et al. Depolymerized holothurian glycosaminoglycan (DHG) prevents neointimal formation in balloon-injured rat carotid artery. Atherosclerosis. 1997;129:27-31.
10. Saga H, Kimura K, Hayashi K, et al. Phenotype-dependent expression of α-smooth muscle actin in visceral smooth muscle cells. Exp Cell Res. 1999;247:279-292.
11. Zubilewicz T, Wronski J, Bourriez A, et al. Injury in vascular surgery: the intimal hyperplastic response. Med Sci Monit. 2001;7:316-324.
12. Schulze C, Smales C, Rubin LL, et al. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J Neurochem. 1997;68:991-1000.
13. Siess W, Zangl KJ, Essler M, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A. 1999;96:6931-6936.
14. Palmetshofer A, Robson SC, Nehls V. Lysophosphatidic acid activates nuclear factor kappa B and induces proinflammatory gene expression in endothelial cells. Thromb Haemost. 1999;82:1532-1537.
15. Siess W: Athero- and thrombogenic action of lysophosphatidic acid and sphingosin-1-phosphate. Biochim Biophys Acta. 2002;582:204-215.
16. Bandoh K, Aoki J, Hosono H, et al. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem. 1999;274:27776-27785.
17. Bandoh K, Aoki J, Taira A, et al. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species: structure-activity relationship of cloned LPA receptors. FEBS Lett. 2000;478:159-165.